arrow
L

Luís R. Lopes

university college london
H指数:43
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence and determinants of asymmetric septal hypertrophy (ASH) in diseases of left ventricular hypertrophy (LVH)

左心室肥厚(LVH)疾病中非对称室间隔肥厚(ASH)的患病率及其影响因素

2026-08-030
OAAI
Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic Cardiomyopathy

基因型独立于LVEF、峰值VO2和NT-proBNP水平预测肥厚型心肌病的心力衰竭

2026-06-100
OAAI
Early Detection of Subclinical Myocardial Dysfunction in Familial Dilated Cardiomyopathy Using Myocardial Work Analysis

使用心肌做功分析对家族性扩张型心肌病进行亚临床心肌功能异常的早期检测

2025-09-300
OAAI
Sepsis-induced myocardial dysfunction diagnosed with strain versus non-strain echocardiography parameters: incidence, evolution and association with prognosis

脓毒症诱导的心肌功能障碍:基于应变与非应变超声心动图参数的诊断、发生率和演变及其与预后的关联

2025-09-250
OAAI
Clinical care of family members of patients with dilated cardiomyopathy

扩张型心肌病患者的家庭成员的临床护理

2025-09-012
OAAI
Hypercontractile phenotype in hypertrophic cardiomyopathy indicates unfavorable hemodynamics, coronary flow and prognosis

Wierzbowska-Drabik, K.; Pálinkás, E.D.; D’Alfonso, M.G.; Mori, F.; Del Franco, A.; Vazquez, J.P.; Re, F.; Tesic, M.; Djordjevic-Dikic, A.; Pálinkás, A.; 等. 肥厚型心肌病中的高收缩性表型表明血流动力学、冠状动脉血流和预后不良。Eur. Heart J. Cardiovasc. Imaging 2025, 26, 1675–1684. [Google Scholar] [CrossRef]

2025-08-011
OA
An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy

来自100,000基因组队列的心肌病患者的线粒体变异分析: m.4300A>G是遗传上难以捉摸的肥厚性心肌病的原因

2024-12-050
OAAI
Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy
2024-12-010
PRE
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases

心力衰竭基因治疗的现状和前景。ESC心力衰竭协会、ESC心血管基因组学理事会和ESC心肌和心包疾病工作组的科学声明

2024-11-220
PRE
Arrhythmic risk stratification in patients with left ventricular ring-like scar
2024-11-011
OA
Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing
2024-07-010
OA